Storia in 2 fonti

Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr

Global investors, led by Societe Generale and Prudential, acquire 3% stake in Anthem Biosciences for ₹1,275 crore.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

thehindubusinessline.comStai leggendo7 h fa

Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr

Societe Generale, Prudential, Ghisallo Capital e altri investitori globali hanno acquisito il 3% di Anthem Biosciences per ₹1,275 crore. L'operazione riflette crescente interesse istituzionale verso India quale hub per biotech manufacturing e outsourcing R&D pharma.

originale

economictimes.indiatimes.com8 h fa

Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr

Global investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a 3 percent stake in Anthem Biosciences. The deal, valued at Rs 1,275 crore, saw…

Leggi questa versione → originale

Timeline cronologica

venerdì 19 giugno 2026·economictimes.indiatimes.com
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr
Global investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a 3 percent stake in Anthem Biosciences.…
venerdì 19 giugno 2026·thehindubusinessline.com
Societe General, Prudential, others buy 3% stake in Anthem Biosciences for ₹1,275 cr
Global investors, led by Societe Generale and Prudential, acquire 3% stake in Anthem Biosciences for ₹1,275 crore.